Skip to main content
SpringerLink
Log in

Comparative Tolerability of Drug Treatment for Nocturnal Enuresis in Children

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Primary nocturnal enuresis is one of the most frequent complaints in paediatric and urologic practice. Physicians face the dilemma of whether or not to treat primary nocturnal enuresis since the trend towards spontaneous remission is countered by social disadvantages and reduced self esteem of the children affected and their families. We reviewed randomised, controlled trials investigating efficacy and adverse effects of current medical treatment for primary nocturnal enuresis. Only desmopressin and imipramine displayed significant effects in reducing wet nights: when compared with baseline bedwetting or placebo controls, 30–70% of the studied children achieved therapeutic success. For drugs such as indometacin or oxybutynin, convincing studies displaying a significant positive effect are still needed. However, considering the adverse effects profiles of desmopressin and imipramine it can be seen that imipramine is associated with about twice as many unwanted reactions. More importantly, a serious adverse effect of imipramine is sudden cardiac arrest. In general, adverse effects with desmopressin are rare and mild, but there have been a number of case reports of hyponatraemic hypervolaemia associated with coma and seizures. Of these, many cases were attributed to excess water intake before taking the drug and all children recovered fully. In summary, if medical treatment is considered, preference should be given to desmopressin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. Norgaard JP, van Gool JD, Hjälmas K, et al. Standardization and definitions in lower urinary tract dysfunction in children. Br J Urol 1998; 81Suppl. 3: 1–16

    PubMed  Google Scholar 

  2. Butler RJ. Annotation: night wetting in children: psychological aspects. J Child Psychol Psychiatry 1998; 39(4): 453–63

    PubMed  CAS  Google Scholar 

  3. von Gontard A, Schaumburg H, Hollmann E, et al. The genetics of enuresis: a review. J Urol 2001 Dec; 166(6): 2438–43

    Google Scholar 

  4. Byrd RS, Weitzman M, Lanphear NE, et al. Bed-wetting in US children: epidemiology and related behaviour problems. Pediatrics 1996; 98(3 Pt 1): 414–9

    PubMed  CAS  Google Scholar 

  5. Trousseau A. Incontinence nocturne de l’urine. Vol. 2. Paris: Clinique Medicale de L’Hotel-Dieu de Paris, 1868

    Google Scholar 

  6. Rittig S, Knudsen UB, Norgaard JP, et al. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 1989 Apr; 256(4 Pt 2): F664–71

    PubMed  CAS  Google Scholar 

  7. Muller D, Marr N, Ankermann T, et al. Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus. Lancet 2002 Feb 9; 359(9305): 495–7

    PubMed  Google Scholar 

  8. Müller D, Florkowki H, Chavez-Kattau K, et al. The effect of desmopressin on short-term memory in children with primary nocturnal enuresis. J Urol 2001 Dec; 166(6): 2432–4

    PubMed  Google Scholar 

  9. de Wied D, Gaffori O, van Ree JM, et al. Central target for the behavioural effects of vasopressin neuropeptides. Nature 1984 Mar 15-21; 308(5956): 276–8

    PubMed  Google Scholar 

  10. Hansen MN, Rittig S, Siggaard C, et al. Intra-individual variability in nighttime urine production and functional bladder capacity estimated by home recordings in patients with nocturnal enuresis. J Urol 2001 Dec; 166(6): 2452–5

    PubMed  CAS  Google Scholar 

  11. Yeung CK, Sit FK, To LK, et al. Reduction in nocturnal functional bladder capacity is a common factor in the pathogenesis of refractory nocturnal enuresis. BJU Int 2002 Aug; 90(3): 302–7

    PubMed  CAS  Google Scholar 

  12. Forsythe WI, Redmond A. Enuresis and spontaneous cure rate: a study of 1129 enuretics. Arch Dis Child 1974 Apr; 49(4): 259–63

    PubMed  CAS  Google Scholar 

  13. Schulpen TW. The burden of nocturnal enuresis. Acta Paediatr 1997 Sep; 86(9): 981–4

    PubMed  CAS  Google Scholar 

  14. Warzak WJ. Psychological implications of nocturnal enuresis. Clin Pediatr (Phila) 1993 Jul; special edition: 38–40

    Google Scholar 

  15. Hjälmas K. Pathophysiology and impact of nocturnal enuresis. Acta Paediatr 1997 Sep; 86(4): 919–22

    PubMed  Google Scholar 

  16. Glazener CMA, Evans JHC, Peto RE. Alarm interventions for nocturnal enuresis in children. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2003

    Google Scholar 

  17. Kamsteeg EJ, Wormhoudt TA, Rijss JP, et al. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 1999 May 4; 18(9): 2394–400

    PubMed  CAS  Google Scholar 

  18. Deen PM, Verdijk MA, Knoers NV, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994 Apr 1; 264(5155): 92–5

    PubMed  CAS  Google Scholar 

  19. van den Ouweland AM, Dreesen JC, Verdijk M, et al. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 1992 Oct; 2(2): 99–102

    PubMed  Google Scholar 

  20. Deen PM, Dahl N, Caplan MJ. The aquaporin-2 water channel in autosomal dominant primary nocturnal enuresis. J Urol 2002 Mar; 167(3): 1447–50

    PubMed  CAS  Google Scholar 

  21. Dimson SB. Desmopressin as a treatment for enuresis [letter]. Lancet 1977 Jun 11; I(8024): 1260

    Google Scholar 

  22. Eggert P, Chavez-Kattau K, Muller D. Age- and weight-related dosage of dDAVP in the treatment of primary nocturnal enuresis [in German]. Klin Padiatr 2001 Nov-Dec; 213(9): 317–20

    PubMed  CAS  Google Scholar 

  23. Birkasova M, Birkas O, Flynn MJ, et al. Desmopressin in the management of nocturnal enuresis in children: a double blind study. Pediatrics 1978 Dec; 62(6): 970–4

    PubMed  CAS  Google Scholar 

  24. Dimson SB. DDAVP and urine osmolality in refractory enuresis. Arch Dis Child 1986 Nov; 61(11): 1104–7

    PubMed  CAS  Google Scholar 

  25. Fjellestad-Paulsen A, Wille S, Harris AS. Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child 1987 Jul; 62(7): 674–7

    PubMed  CAS  Google Scholar 

  26. Folwell AJ, Macdiarmid SA, Crowder HJ, et al. Desmopressin for nocturnal enuresis: urinary osmolality and response. Br J Urol 1997 Sep; 80(3): 480–4

    PubMed  CAS  Google Scholar 

  27. Janknegt RA, Smans AJ. Treatment with desmopressin in severe nocturnal enuresis in childhood. Br J Urol 1990 Nov; 66(5): 535–7

    PubMed  CAS  Google Scholar 

  28. Post EM, Richmann RA, Blackett PR, et al. Desmopressin response of enuretic children: effects of age and frequency of enuresis. Am J Dis Child 1983 Oct; 137(10): 962–3

    PubMed  CAS  Google Scholar 

  29. Rittig S, Knudsen UB, Sorensen S, et al. Long term double blind cross-over study of desmopressin intranasal spray in the management of nocturnal enuresis. In: Meadow SR, editor. Desmopressin in enuresis. Proceedings of an International Symposium held at the Royal College of Physicians. London: Horus Medical Publications, 1988: 43–55

    Google Scholar 

  30. Terho P, Kekomaki M. Management of nocturnal enuresis with a vasopressin analogue. J Urol 1984 May; 131(5): 925–7

    PubMed  CAS  Google Scholar 

  31. Terho P. Desmopressin in nocturnal enuresis. J Urol 1991 Apr; 145(4): 818–20

    PubMed  CAS  Google Scholar 

  32. Tuvemo T. DDAVP in childhood nocturnal enuresis. Acta Paediatr Scand 1978 Nov; 67(6): 753–5

    PubMed  CAS  Google Scholar 

  33. Stenberg A, Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics 1994 Dec; 94(6 Pt 1): 841–6

    PubMed  CAS  Google Scholar 

  34. Matthiesen TB, Rittig S, Djurhuus JC, et al. A dose titration, and an open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J Urol 1994 Feb; 151(2): 460–3

    PubMed  CAS  Google Scholar 

  35. Skoog SJ, Stokes A, Turner KL. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. J Urol 1997 Sep; 158(3 Pt 2): 1035–40

    PubMed  CAS  Google Scholar 

  36. Glazener CMA, Evans JHC. Desmopressin for nocturnal enuresis in children. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. Oxford: Update Software, 2003

    Google Scholar 

  37. Bradbury MG, Meadow SR. Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis. Acta Paediatr 1995 Sep; 84(9): 1014–8

    PubMed  CAS  Google Scholar 

  38. Burke JR, Mizusawa Y, Chan A, et al. A comparison of amitriptyline, vasopressin, and amitriptyline with vasopressin in nocturnal enuresis. Pediatr Nephrol 1995 Aug; 9(4): 438–40

    PubMed  CAS  Google Scholar 

  39. Faraj G, Cochat P, Cavailles ML, et al. Treatment of isolated nocturnal enuresis: alarm or desmopressin [in French]. Arch Pediatr 1999 Mar; 6(3): 271–4

    PubMed  CAS  Google Scholar 

  40. Holt J, Borresen B. Enuresis in school children in Bodo: a therapeutic trial with a vasopressin analog: desmopressin and imipramine [in Norwegian]. Tidsskr Nor Laegeforen 1986 Mar 20; 106(8): 651–4

    PubMed  CAS  Google Scholar 

  41. Kahan E, Morel D, Amir J, et al. A controlled of desmopressin and behavioural therapy for nocturnal enuresis. Medicine (Baltimore) 1998 Nov; 77(6): 384–8

    CAS  Google Scholar 

  42. Longstaffe S, Moffatt ME, Whalen JC. Behavioural and self-concept changes after six months of enuresis treatment: a randomized, controlled trial. Pediatrics 2000 Apr; 105(4 Pt 2): 935–40

    PubMed  CAS  Google Scholar 

  43. Martin Hernandez E, Fernandez Oviez JM, Guzman-Guzman A, et al. Clinical effectiveness and safety of desmopressin in the treatment of infantile enuresis [in Spanish]. Rev Esp Pediatr 1993; 49: 497–501

    Google Scholar 

  44. Radmayr C, Schlager A, Studen M, et al. Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis. Eur Urol 2001 Aug; 40(2): 201–5

    PubMed  CAS  Google Scholar 

  45. Rodriguez do Forno, Ariceta Iraola G. Results of a therapeutic strategy against monosymptomatic nocturnal enuresis background [in Spanish]. An Esp Pediatr 2001; 54: 38–43

    Google Scholar 

  46. Wille S. Comparison of desmopressin and enuresis alarm for nocturnal enuresis. Arch Dis Child 1986 Jan; 61(1): 30–3

    PubMed  CAS  Google Scholar 

  47. Yap HK, Chao SM, Tan AY, et al. Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children. J Paediatr Child Health 1998 Apr; 34(2): 151–3

    PubMed  CAS  Google Scholar 

  48. Hjalmås K, Hanosen E, Hellstrom AL, et al. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study: Swedish Enuresis Trial (SWEET) Group. Br J Urol 1998 Nov; 82(5): 704–9

    PubMed  Google Scholar 

  49. Chiozza ML, del Gado R, di Toro R, et al. Italian multicentre open trial on DDAVP spray in nocturnal enuresis. Scand J Urol Nephrol 1999 Feb; 33(1): 42–8

    PubMed  CAS  Google Scholar 

  50. Hamano S, Yamanishi T, Igarashi T, et al. Functional bladder capacity as a predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis. Eur Urol 2000 Jun; 37(6): 718–22

    PubMed  CAS  Google Scholar 

  51. Leebeck-Groenewegen A, Blom J, Sukhai R, et al. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis. J Urol 2001 Dec; 166(6): 2456–8

    Google Scholar 

  52. Miller K, Klauber GT. Desmopressin acetate in children with severe primary nocturnal enuresis. Clin Ther 1990 Jul-Aug; 12(4): 357–66

    PubMed  CAS  Google Scholar 

  53. Schulman SL, Stokes A, Salzman PM. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. J Urol 2001 Dec; 166(6): 2427–31

    PubMed  CAS  Google Scholar 

  54. Vertucci P, Lanzi C, Capece G, et al. Desmopressin and imipramine in the management of nocturnal enuresis: a multicentre study. Br J Clin Pract 1997 Jan-Feb; 51(1): 27–31

    PubMed  CAS  Google Scholar 

  55. Hjålmas K, Bengtsson B. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr (Phila) 1993 Jul; Spec No: 19–24

    Google Scholar 

  56. Williford SL, Bernstein SA. Intranasal desmopressin-induced hyponatremia. Pharmacotherapy 1996 Jan-Feb; 16(1): 66–74

    PubMed  CAS  Google Scholar 

  57. Vic P, Queinnec C, Durelle-Caillard P, et al. Troubles du comportement chez un enfant traité par desmopressine pour 78. énurésie. Arch Pediatr 2000; 7: 1128–9

    PubMed  CAS  Google Scholar 

  58. Robson WL, Shashi V, Nagaraj S, et al. Water intoxication in a patient with the Prader-Willi syndrome treated with desmopressin for nocturnal enuresis. J Urol 1997 Feb; 157(2): 646–7

    PubMed  CAS  Google Scholar 

  59. Neuhaus TJ, von der Heiden-Ranz M. Hyponatraemia and cerebral convulsion after a single dose of intranasal DDAVP [letter]. Pediatr Nephrol 1997 Aug; 11(4): 527

    PubMed  CAS  Google Scholar 

  60. Donoghue MB, Latimer ME, Pillsbury HL, et al. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis. Arch Pediatr Adolesc Med 1998 Mar; 152(3): 290–2

    PubMed  CAS  Google Scholar 

  61. Jensen SS, Hansen LP. Acute water intoxication caused by intranasal desmopressin: Minirin [in Danish]. Ugeskr Laeger 1997 Jan 13; 159(3): 306–7

    PubMed  CAS  Google Scholar 

  62. Metha U. Hyponatraemic convulsions and coma in a patient with enuresis treated with desmopressin [letter]. S Afr Med J 1997; 87: 79

    Google Scholar 

  63. Schwab M, Wenzel D, Ruder H. Hyponatraemia and cerebral convulsions due to short term DDAVP therapy for control of enuresis nocturna. Eur J Pediatr 1996 Jan; 155(1): 46–8

    PubMed  CAS  Google Scholar 

  64. Lebl J, Kolská M, Zavacká A, et al. Cerebral oedema in enuretic children during low-dose desmopressin treatment: a preventable complication. Eur J Pediatr 2001 Mar; 160(3): 159–62

    PubMed  CAS  Google Scholar 

  65. Odeh M, Oliven A. Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis. J Clin Pharamacol 2001 May; 41(5): 582–4

    CAS  Google Scholar 

  66. Apakama DC, Bleetman A. Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis. J Accid Emerg Med 1999 May; 16(3): 229–30

    PubMed  CAS  Google Scholar 

  67. Schwartz ID. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis. Arch Pediatr Adolesc Med 1998 Oct; 152(10): 1037–8

    PubMed  CAS  Google Scholar 

  68. Bernstein SA, Williford SL. Intranasal desmopressin-associated hyponatremia: a case report and literature review. J Fam Pract 1997 Feb; 44(2): 203–8

    PubMed  CAS  Google Scholar 

  69. Shindel A, Tobin G, Klutke C. Hyponatremia associated with desmopressin for the treatment of nocturnal polyuria. Urology 2002 Aug; 60(2): 344

    PubMed  Google Scholar 

  70. Segal-Kuperschmit D, Dali-Gotfrid O, Luder A. Water intoxication following desmopressin overdose [in Hebrew]. Harefuah 1997 Apr; 132(7): 465–7

    PubMed  CAS  Google Scholar 

  71. Wieting JM, Dykstra DD, Ruggiero MP, et al. Central nervous system ischemia after varicalla infection and desmopressin therapy for enuresis. J Am Osteopath Assoc 1997 May; 97(5): 293–5

    PubMed  CAS  Google Scholar 

  72. Fritz GK, Rockney RM, Yeung AS. Plasma levels and efficacy of imipramine treatment for enuresis. J Am Acad Child Adolesc Psychiatry 1994 Jan; 33(1): 60–4

    PubMed  CAS  Google Scholar 

  73. Nocturnal enuresis. British National Formulary, 2002; vol. 32: 405–6

  74. MacLean REG. Imipramine hydrochloride (Tofranil) and enuresis [letter]. Am J Psychiatry 1960; 117: 551

    PubMed  CAS  Google Scholar 

  75. Bindelglas PM, Dee G, Enos FA. Medical and psychosocial factors in enuretic children treated with imipramine hydrochloride. Am J Psychiatry 1968; 124: 1107–12

    Google Scholar 

  76. Fournier JP, Garfinkel LPD, Bond A, et al. Pharmacological and behavioural management of enuresis. J Am Acad Child Adolesc Psychiatry 1987; 26(6): 849–53

    PubMed  CAS  Google Scholar 

  77. Kolvin I, Taunch J, Currah J, et al. Enuresis: a descriptive analysis and a controlled trial. Dev Med Child Neurol 1972 Dec; 14(6): 715–26

    PubMed  CAS  Google Scholar 

  78. Manhas RS, Sharma JD. Tofranil (imipramine) in childhood enuresis: a controlled clinical trial of tofranil (imipramine) in the treatment of 72 cases of childhood enuresis in Kashmir. Indian Pract 1967; 66: 663–9

    Google Scholar 

  79. Martin GI. Imipramine pamoate in the treatment of childhood enuresis: a double-blind study. Am J Dis Child 1971; 122(1): 42–7

    PubMed  CAS  Google Scholar 

  80. Maxwell C, Seldrup J. General practioners’ forum: imipramine in treatment of childhood enuresis. Practitioner 1971; 207(242): 809–14

    PubMed  CAS  Google Scholar 

  81. Moltke H, Verder H. Enuresis nocturna: a double-blind study with furosemide, imipramine and placebo [in Danish]. Ugeskr Laeger 1979; 141(21): 1399–402

    PubMed  CAS  Google Scholar 

  82. Poussaint AF, Ditman KS, Greenfield R. A controlled study of imipramine (Tofranil) in the treatment of childhood enuresis. J Pediatr 1965; 67: 283–90

    Google Scholar 

  83. Schroder G, Fliessbach R. A controlled therapeutic attempt to treat sixty-two enuretic children with Tofranil mite [in German]. Monatsschr Kinderheilkd 1971; 119(4): 148–51

    PubMed  CAS  Google Scholar 

  84. Shaffer D, Costello AJ, Hill ID. Control of enuresis with imipramine. Arch Dis Child 1968; 43(232): 665–71

    PubMed  CAS  Google Scholar 

  85. Smellie JM, McGrigor VS, Meadow SR, et al. Nocturnal enuresis: a placebo controlled trial of two antidepressant drugs. Arch Dis Child 1996; 75(1): 62–6

    PubMed  CAS  Google Scholar 

  86. Ingle VN, Panase V. Enuresis: a comparative study of imipramine and tranquillisers in its management. Indian Pediatr 1968 May; 5(5): 222–5

    PubMed  CAS  Google Scholar 

  87. Fernández de Gatta MM, Galindo P, Rey F, et al. The influence of clinical and pharmacological features on enuresis treatment with imipramine. Br J Clin Pharmacol 1990; 30: 693–8

    Google Scholar 

  88. Kumazawa-Ichikawa MR, Franco-Tostado B, Ruvalcaba-Aceves R. Management of primary nocturnal enuresis in school children with slow learning ability: usefulness of imipramine [in Spanish]. Bol Med Hosp Infant Mex 1990; 47(6): 390–4

    PubMed  CAS  Google Scholar 

  89. Thomsen W, Reid WB, Hebeler J. Effect of tofranil on enuretic boys. Dis Nerv Syst 1967 Mar; 28(3): 167–9

    PubMed  CAS  Google Scholar 

  90. Attenburrow AA, Stanley TV, Holland RP. Nocturnal enuresis: a study. Practitioner 1984 Jan; 228(1387): 99–102

    PubMed  CAS  Google Scholar 

  91. Lister-Sharp D, O’Meara S, Bradley M, et al. A systematic review of the effectiveness of interventions for managing childhood nocturnal enuresis. Vol. CRD Report 11, York: NHS Centre for reviews and dissemination, University of New York. York: Publishing Services Ltd, 1997

    Google Scholar 

  92. Swanson JR, Jones GR, Krasselt W, et al. Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci 1997 Mar; 42(2): 335–9

    PubMed  CAS  Google Scholar 

  93. Varley CK. Sudden death of a child treated with imipramine: case study. J Child Adolesc Psychopharmacol 2000 Winter; 10(4): 321–5

    PubMed  CAS  Google Scholar 

  94. Varley CK, McClellan J. Case study: two additional sudden deaths with tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry 1997 Mar; 36(3): 390–4

    PubMed  CAS  Google Scholar 

  95. Biederman J. Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry 1991 May; 30(3): 495–8

    PubMed  CAS  Google Scholar 

  96. Popper CW, Ziminitzky B. Sudden death putatively related to desipramine treatment in youth: a fifth case and a review of speculative mechanisms. J Child Adolesc Psychopharmacol 1995; 5: 283–300

    Google Scholar 

  97. Riddle MA, Geller B, Ryan ND. Case study: another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993; 32: 792–7

    PubMed  CAS  Google Scholar 

  98. Riddle MA, Nelson JC, Kleinman CS, et al. Sudden death in children receiving Norpramin®: a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiaty 1991 Jan; 30(1): 104–8

    CAS  Google Scholar 

  99. Fletcher SE, Case CL, Sallee FR, et al. Prospective study of the electrocardiographic effects of imipramine in children. J Pediatr 1993 Apr; 122(4): 652–4

    PubMed  CAS  Google Scholar 

  100. Wilens TE, Biederman J, Baldessarini RJ, et al. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 1996 Nov; 35(11): 1491–501

    PubMed  CAS  Google Scholar 

  101. McFee RB, Caraccio TR, Mofenson HC. Selected tricyclic antidepressant ingestions involving children 6 years or less. Acad Emerg Med 2001; 8(2): 139–44

    PubMed  CAS  Google Scholar 

  102. Gire C, Dubus JC, Garnier JM, et al. Imipramine withdrawal syndrome during a treatment for enuresis [in French]. Pediatrie 1992; 47(12): 835–7

    PubMed  CAS  Google Scholar 

  103. Lovering JS, Tallett SE, McKendry JB. Oxybutinin efficacy in the treatment of primary enuresis. Pediatrics 1988 Jul; 82(1): 104–6

    PubMed  CAS  Google Scholar 

  104. Varan B, Saatci U, Ozen S, et al. Efficacy of oxybutinin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis. Turk J Pediatr 1996; 38(2): 155–9

    PubMed  CAS  Google Scholar 

  105. Al-Waili NSD. Indomethacin suppository to treat primary nocturnal enuresis: double-blind study. J Urol 1989 Nov; 142(5): 1290–2

    PubMed  CAS  Google Scholar 

  106. Natochin YV, Kuznetsova AA. Nocturnal enuresis: correction of renal function by desmopressin and diclofenac. Pediatr Nephrol 2000 Jan; 14(1): 42–7

    PubMed  CAS  Google Scholar 

  107. Al-Waili NS. Carbamazepine to treat primary nocturnal enuresis: double blind study. Eur J Med Res 2000 Jan 26; 5(1): 40–4

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of founding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the contents of this manuscript.

Author information

Authors and Affiliations

  1. Department of Pediatric Nephrology, Charite Medical Faculty, Humboldt University, Berlin, Germany

    Dominik Müller

  2. Department of Neonatology, Charite Medical Faculty, Humboldt University, Berlin, Germany

    Charles C. Roehr

  3. University Children’s Hospital, Schwanenweg 20, 24113, Kiel, Germany

    Paul Eggert

Authors
  1. Dominik Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles C. Roehr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Eggert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Eggert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, D., Roehr, C.C. & Eggert, P. Comparative Tolerability of Drug Treatment for Nocturnal Enuresis in Children. Drug-Safety 27, 717–727 (2004). https://doi.org/10.2165/00002018-200427100-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200427100-00002

Keywords

Search

Navigation